American Century Companies Inc. Sells 25,688 Shares of Cigna Group $CI

American Century Companies Inc. cut its holdings in Cigna Group (NYSE:CI) by 13.7% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 162,371 shares of the health services provider’s stock after selling 25,688 shares during the quarter. American Century Companies Inc.’s holdings in Cigna Group were worth $46,804,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of CI. Pathway Financial Advisers LLC raised its stake in Cigna Group by 2.3% during the 2nd quarter. Pathway Financial Advisers LLC now owns 1,501 shares of the health services provider’s stock worth $496,000 after buying an additional 34 shares during the period. Armstrong Advisory Group Inc. increased its holdings in shares of Cigna Group by 17.7% during the third quarter. Armstrong Advisory Group Inc. now owns 226 shares of the health services provider’s stock valued at $65,000 after acquiring an additional 34 shares in the last quarter. HM Payson & Co. increased its holdings in shares of Cigna Group by 0.9% during the third quarter. HM Payson & Co. now owns 3,785 shares of the health services provider’s stock valued at $1,091,000 after acquiring an additional 35 shares in the last quarter. Carr Financial Group Corp raised its position in shares of Cigna Group by 5.3% during the third quarter. Carr Financial Group Corp now owns 709 shares of the health services provider’s stock worth $204,000 after purchasing an additional 36 shares during the period. Finally, Natural Investments LLC lifted its holdings in shares of Cigna Group by 2.0% in the 3rd quarter. Natural Investments LLC now owns 1,843 shares of the health services provider’s stock worth $531,000 after purchasing an additional 36 shares in the last quarter. 86.99% of the stock is currently owned by institutional investors.

Cigna Group Stock Down 1.2%

Shares of NYSE CI opened at $281.21 on Friday. Cigna Group has a 12 month low of $239.51 and a 12 month high of $350.00. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.74. The firm has a market capitalization of $74.11 billion, a price-to-earnings ratio of 12.68, a PEG ratio of 0.99 and a beta of 0.27. The business has a 50-day moving average of $280.80 and a 200-day moving average of $284.43.

Cigna Group (NYSE:CI) last announced its earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.88 by $0.20. The company had revenue of $72.50 billion during the quarter, compared to analyst estimates of $69.53 billion. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The firm’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same period in the previous year, the business earned $6.64 earnings per share. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Sell-side analysts expect that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th will be issued a $1.56 dividend. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date of this dividend is Thursday, March 5th. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. Cigna Group’s payout ratio is 27.23%.

Analyst Upgrades and Downgrades

CI has been the topic of a number of recent research reports. Piper Sandler dropped their price objective on shares of Cigna Group from $374.00 to $370.00 and set an “overweight” rating on the stock in a research note on Tuesday. Truist Financial boosted their target price on shares of Cigna Group from $320.00 to $350.00 and gave the stock a “buy” rating in a research report on Tuesday, February 17th. Leerink Partners raised their price target on shares of Cigna Group from $270.00 to $297.00 and gave the company a “market perform” rating in a research report on Friday, February 6th. TD Cowen lifted their price target on Cigna Group from $333.00 to $338.00 and gave the company a “buy” rating in a research note on Monday, February 9th. Finally, Sanford C. Bernstein reissued a “market perform” rating on shares of Cigna Group in a research note on Wednesday. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat, Cigna Group presently has an average rating of “Moderate Buy” and an average price target of $330.42.

Key Stories Impacting Cigna Group

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Cigna received an independent credit-rating vote of confidence: AM Best affirmed A (Excellent) FSR and “a+” long‑term issuer credit ratings for Cigna’s core life/health subsidiaries — supports financial stability and capital strength. AM Best affirms ratings
• Positive Sentiment: Cigna formally named President & COO Brian Evanko as its next CEO (effective July 1) and said Cordani will move to executive chair; management also reaffirmed 2026 financial outlook — the internal succession and guidance reaffirmation reduce execution/guidance risk versus an outsider pick. Cigna appoints Brian Evanko
• Neutral Sentiment: Cigna executives appeared at the TD Cowen healthcare conference this week — useful for incremental detail and Q&A but not a market-moving catalyst on its own. TD Cowen presentation notice
• Neutral Sentiment: Broader health-care weakness intraday pressured peers as the NYSE Health Care Index slipped — sector moves amplify company-specific headlines but are not unique to CI. Sector update
• Negative Sentiment: Market reaction to the CEO transition has been negative in the near term — investors appear concerned about leadership change and potential strategic shifts at Evernorth/PBM despite the internal appointment. Seeking Alpha on leadership transition
• Negative Sentiment: Piper Sandler (per recent coverage) issued a cautious note on near‑term outlook for CI, which can weigh on sentiment even if other analysts remain constructive. Piper Sandler pessimistic forecast
• Negative Sentiment: Insider selling was reported (director-level sale of ~1.7k shares) — small in isolation but often cited by traders as a short-term negative signal. Insider trade filing

Insider Transactions at Cigna Group

In other Cigna Group news, insider Everett Neville sold 1,719 shares of Cigna Group stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $496,636.29. Following the sale, the insider directly owned 5,670 shares of the company’s stock, valued at approximately $1,638,119.70. The trade was a 23.26% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Nicole S. Jones sold 2,307 shares of the business’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the sale, the insider owned 32,647 shares in the company, valued at approximately $9,432,044.77. This trade represents a 6.60% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.70% of the stock is currently owned by insiders.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.